Diet and rosacea: the role of dietary change in the management of rosacea

Diet and rosacea: the role of dietary change in the management of rosacea

Authors

  • Emma Weiss Baylor College of Medicine
  • Rajani Katta Baylor College of Medicine, Houston, TX, USA

Keywords:

rosacea, diet, gut-skin connection

Abstract

Dietary change may play a role in the therapy of rosacea. Certain foods and beverages may act as "triggers" for rosacea exacerbations. These may be divided into heat-related, alcohol-related, capsaicin-related, and cinnamaldehyde-related. One potential pathogenic mechanism may be via the activation of transient receptor potential cation channels, which result in neurogenic vasodilatation. Further research is needed on the role of the gut skin connection in rosacea. Epidemiologic studies suggest that patients with rosacea have a higher prevalence of gastrointestinal disease, and one study reported improvement in rosacea following successful treatment of small intestinal bacterial overgrowth. While further research is required in this area, patients may be advised on measures to support a healthy gut microbiome, including the consumption of a fiber-rich (prebiotic) diet. 

Author Biographies

Emma Weiss, Baylor College of Medicine

Department of Medicine, Medical Student

Rajani Katta, Baylor College of Medicine, Houston, TX, USA

Division of Dermatology, Clinical Faculty

References

Rainer BM, Fischer AH, Luz Felipe Da Silva D, Kang S, Chien AL. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: Results of a case-control study A portion of this work was presented at the Society for Investigative Dermatology Annual Meeting in Albuquerque, New Mexico, May 7-10. J Am Acad Dermatol. 2015;73(4):604-608. doi:10.1016/j.jaad.2015.07.009.

Two AM, Wu W, Gallo RL, Hata TR. Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749-758. doi:10.1016/j.jaad.2014.08.028.

Duman N, Ersoy Evans S, Atakan N. Rosacea and cardiovascular risk factors: a case control study. J Eur Acad Dermatol Venereol. 2013:1165-1169. doi:10.1111/jdv.12234.

Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13(8):975-980. doi:10.1038/nm1616.

Sulk M, Seeliger S, Aubert J, et al. Distribution and Expression of Non-Neuronal Transient Receptor Potential (TRPV) Ion Channels in Rosacea. J Invest Dermatol. 2012;132(4):1253-1262. doi:10.1038/jid.2011.424.

Ferrer L, Ravera I, Silbermayr K. Immunology and pathogenesis of canine demodicosis. Vet Dermatol. 2014;25(5):427-e65. doi:10.1111/vde.12136.

Koçak M, Yaǧli S, Vahapoǧlu G, Ekşioǧlu M. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea: A randomized double-blind placebo-controlled study. Dermatology. 2002;205(2-3):265-270. doi:10.1159/000065849.

Bielenberg DR, Bucana CD, Sanchez R, et al. Molecular Regulation of UVB-Induced Cutaneous Angiogenesis. J Invest Dermatol. 1998;111(5):864-872. doi:10.1046/j.1523-1747.1998.00378.x.

Yamasaki K, Gallo RL, Li G, et al. The molecular pathology of rosacea. J Dermatol Sci. 2009;55(2):77-81. doi:10.1016/j.jdermsci.2009.04.007.

Drake L. Hot Sauce, Wine and Tomatoes Cause Flare-ups, Survey Finds | Rosacea.org. https://www.rosacea.org/rr/2005/fall/article_3.php. Accessed June 2, 2017.

Scheman A, Rakowski EM, Chou V, Chhatriwala A, Ross J, Jacob SE. Balsam of Peru: past and future. Dermatitis. 2013;24(4):153-160. doi:10.1097/DER.0b013e31828afab2.

Aubdool AA, Brain SD. Neurovascular Aspects of Skin Neurogenic Inflammation. J Investig Dermatology Symp Proc. 2011;15(1):33-39. doi:10.1038/jidsymp.2011.8.

Campbell TM, Neems R, Moore J. Case reports: severe exacerbation of rosacea induced by cinnamon supplements. J Drugs Dermatology. 2008;7(6):8-10.

Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol. 2017;176(1):100-106. doi:10.1111/bjd.14930.

Argenziano G, Donnarumma G, Iovene MR, Arnese P, Baldassarre MA, Baroni A. Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients. In: International Journal of Dermatology.Vol 42.; 2003:601-604. doi:10.1046/j.1365-4362.2003.01817.x.

Diaz C, O’Callaghan CJ, Khan a, Ilchyshyn a. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol. 2003;83(4):282-286. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12926800.

Gravina A, Federico A, Ruocco E, et al. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United Eur Gastroenterol J. 2015;3(1):17-24. doi:10.1177/2050640614559262.

Gürer MA, Erel A, Erbaş D, Çaǧlar K, Atahan Ç̧. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol. 2002;41(11):768-770. doi:10.1046/j.1365-4362.2002.01452.x.

Zandi S, Shamsadini S, Zahedi MJ, Hyatbaksh M. Rosacea and Helicobacter pylori. East Mediterr Heal J La Rev sante la Mediterr Orient alMajallah alsihhiyah lisharq almutawassit. 1995;46(10):675.

Boixeda de Miquel D, Vázquez Romero M, Vázquez Sequeiros E, et al. Effect of Helicobacter pylori eradication therapy in rosacea patients. Rev Esp Enferm Dig. 2006;98(7):501-509.

Parodi A, Paolino S, Greco A, et al. Small Intestinal Bacterial Overgrowth in Rosacea: Clinical Effectiveness of Its Eradication. Clin Gastroenterol Hepatol. 2008;6(7):759-764. doi:10.1016/j.cgh.2008.02.054.

Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatology Venereol. 2002;16(4):328-333. doi:10.1046/j.1468-3083.2002.00497.x.

Tüzün Y, Keskin S, Kote E. The role of Helicobacter pylori infection in skin diseases: Facts and controversies. Clin Dermatol. 2010;28(5):478-482. doi:10.1016/j.clindermatol.2010.03.002.

Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders - a population-based cohort study. Br J Dermatol. 2016:1-7. doi:10.1111/bjd.14930.

Wu C-Y, Chang Y-T, Juan C-K, et al. Risk of inflammatory bowel disease in patients with rosacea: Results from a nationwide cohort study in Taiwan. J Am Acad Dermatol. 2017;(155):1-7. doi:10.1016/j.jaad.2016.11.065.

Li WQ, Cho E, Khalili H, Wu S, Chan AT, Qureshi AA. Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women. Clin Gastroenterol Hepatol. 2016;14(2):220-225.e3. doi:10.1016/j.cgh.2015.09.013.

Chang ALS, Raber I, Xu J, et al. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol. 2015;135(6):1548-1555. doi:10.1038/jid.2015.53.

Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet. 2015;47(2):172-179. doi:10.1038/ng.3176.

Drago F, De Col E, Agnoletti AF, et al. The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up. J Am Acad Dermatol. 2016;75(3):e113-e115. doi:10.1016/j.jaad.2016.01.059.

Kendall SN. Remission of rosacea induced by reduction of gut transit time. 2004:297-299.

Chang Y-S, Trivedi MK, Jha A, Lin Y-F, Dimaano L, García-Romero MT. Synbiotics for Prevention and Treatment of Atopic Dermatitis. JAMA Pediatr. 2016;170(3):236. doi:10.1001/jamapediatrics.2015.3943.

Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice. Sci Transl Med. 2009;1(6):6ra14-6ra14. doi:10.1126/scitranslmed.3000322.

Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017;8(2):172-184. doi:10.1080/19490976.2017.1290756.

Picardo M, Ottaviani M. Skin Microbiome and Skin Disease The Example of Rosacea. 2014;48(December):85-86.

Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol. 2013;6(1):39-51. doi:10.1177/1756283X12459294.

Gibson GR, Scott KP, Rastall RA, et al. Dietary prebiotics: current status and new definition. Food Sci Technol Bull Funct Foods. 2010;7(1):1-19. doi:10.1616/1476-2137.15880.

Kaoutari A El, Armougom F, Gordon JI, Raoult D, Henrissat B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat Rev Microbiol. 2013;11(7):497-504. doi:10.1038/nrmicro3050.

Desai MS, Seekatz AM, Koropatkin NM, et al. A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. Cell. 2016;167(5):1339-1353.e21. doi:10.1016/j.cell.2016.10.043.

Hill C, Guarner F, Reid G, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514. http://dx.doi.org/10.1038/nrgastro.2014.66.

Scourboutakos MJ, Franco-Arellano B, Murphy SA, Norsen S, Comelli EM, L’Abbé MR. Mismatch between probiotic benefits in trials versus food products. Nutrients. 2017;9(4). doi:10.3390/nu9040400.

Kober M, Bowe WP. The effect of probiotics on immune regulation, acne, and photoaging. Int J Women ’ s Dermatology. 2015;1(2):85-89. doi:10.1016/j.ijwd.2015.02.001.

Hacini-Rachinel F, Gheit H, Le Luduec JB, Dif F, Nancey S, Kaiserlian D. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One. 2009;4(3). doi:10.1371/journal.pone.0004903.

Benson KF, Redman KA, Carter SG, et al. Probiotic metabolites from Bacillus coagulans GanedenBC30TM support maturation of antigen-presenting cells in vitro. World J Gastroenterol. 2012;18(16):1875-1883. doi:10.3748/wjg.v18.i16.1875.

Gueniche A, Benyacoub J, Philippe D, et al. Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur J Dermatology. 2010;20(6):731-737. doi:10.1684/ejd.2010.1108.

Maroon JC, Bost JW. Omega-3 Fatty acids (fish oil) as an anti-inflammatory: An alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol. 2006;65(4):326-331. doi:10.1016/j.surneu.2005.10.023.

Bhargava R, Kumar P, Kumar M, Mehra N, Mishra A. A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int J Ophthalmol. 2013;6(6):811-816. doi:10.3980/j.issn.2222-3959.2013.06.13.

Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009;12(6):646-652. doi:10.1097/MCO.0b013e3283312956.

Sharquie KE, Najim R a, Al-salman HN, Fibms D. Clinical trial Oral zinc sulfate in the treatment of rosacea : A double-blind, placebo-controlled study. Int J Dermatol. 2006;45(7):857-861.

Bamford JTM, Gessert CE, Haller I V, Kruger K, Johnson BP. Clinical trial Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea. Int Journal Dermatology. 2012;51(4):459-462.

Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Assessment of the risk of cardiovascular disease in patients with rosacea. J Am Acad Dermatol. 2016;75(2):336-339. doi:10.1016/j.jaad.2016.02.1158.

Downloads

Published

2017-10-31

Issue

Section

Review

How to Cite

1.
Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol Pract Concept [Internet]. 2017 Oct. 31 [cited 2024 May 19];7(4):31-7. Available from: https://dpcj.org/index.php/dpc/article/view/dermatol-pract-concept-articleid-dp0704a08

Share